NEW YORK, May 31, 2011 Reportlinker.com announces that a new market research report is available in its catalogue:
Global Cell/Tissue Culture Supplies Industry
Advertisement
http://www.reportlinker.com/p098415/Global-Cell/Tissue-Culture-Supplies-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Biotechnology
Advertisement
This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in US$ Million by the following Product Segments: Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 131 companies including many key and niche players such as Affymetrix, Inc., AMRESCO, Inc., BD Biosciences, Cell Culture Technologies, LLC, Cell Essentials, Inc., Irvine Scientific, Life Technologies Corporation, Lonza Biologics Plc, Mediatech, Inc., Millipore Corporation, Medi-Cult A/S, MP Biomedicals, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, SAFC Biosciences, and Vitrolife AB. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
CELL/TISSUE CULTURE SUPPLIES MCP-3538
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 2
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
Cell/Tissue Culture Media, Sera and Reagents 3
2. MARKET DYNAMICS 5
Outlook 5
Biopharmaceutical Drugs Fuel Cell Culture Market 5
Market Scenario 6
Industrial vs. Academic 6
Biotechnology Sector - Affected by Collapse of Capital Market 6
Global Market Analysis 6
Market Structure 7
3. TRENDS AND ISSUES 8
US Government's Policies to Boost Cell Culture Market 8
Surging Demand for Cell Culture Products 8
Stem Cells and Vaccines - Key Drivers 8
Growing Acceptance for Hi-Veg Culture Media 8
Fed-Batch Cultures - a Big Hit with Large-Scale Bioprocessors 9
Changing Trend Towards Serum-Free Media 9
Proteomics and Pharmacokinetics to Drive Market Growth 9
Bioresearch and Cell Culture in Protein-Based Drug Development 10
CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture 11
Sluggish Fetal Bovine Serum Market 11
Specialty Media Demand on Rise 11
Emerging Alternatives to Conventional Serum Supplemented Media 12
Growth of Defined Media 12
Regulations Prompt Change in Trends 12
Media Optimization 12
Cell-Line Engineering Vs. Cell Culture Media 12
Other Trends 13
Underlying Threat to Cell Culture Industry 13
Manufacture-on-Demand: Gaining Momentum 13
Move Towards Contract Manufacturing 13
Factors Impacting Growth 14
Business Models Driving the Need for Contract Manufacturing 14
Trends in Contract Manufacturing 14
Target Sectors for Contract Manufacturers 14
4. END-USE ANALYSIS 16
End-Use Applications 16
Cell Therapy 16
Growing by Leaps and Bounds 16
Cell Therapy Applications 17
Key Factors Affecting the Cell Therapy Market 17
Future Trends 17
Related Market Sectors 17
Progenitor Cell Therapy 17
Stem Cell Therapy 18
Other Related Technologies 19
Somatic Cell Nuclear Transfer (SCNT) 19
Tissue Engineering 19
End Use Industries 19
5. CELL/TISSUE CULTURE: PHYSIOLOGICAL OVERVIEW 20
Introduction 20
History 20
Plant Cell and Tissue Culture (PCTC) 24
Cell/Tissue Culture Media, Sera and Reagents 27
Classical Media 27
Specialty Media 28
Serum 28
Fetal Bovine Serum 28
Serum-Free Media 28
Cell Culture Reagents 29
Role of Tissue Culture in the Growth of Cell Types 29
Equipment 29
Storage and Preservation 29
Maintenance 30
Growth Pattern 30
Harvesting 30
Media and Growth Requirements 31
Physiological Parameters 31
Medium Requirements (Often Empirical) 31
Feeding 31
Safety Precautions 31
Methods of Tissue Culture 32
Preparation of Media 32
Growth and Morphology 32
Sub Culturing Adherent Cells 32
Thawing Frozen Cells 32
Freezing Cells 32
Cell Culture Contamination - A Looming Problem 33
Classification 33
Major Cell Culture Contaminants 33
Chemical Contamination 33
Types and Sources of Potential Chemical Contaminants 33
Varied Sources of Chemical Contamination 34
Media and Components 34
Sera 34
Water 35
Storage Vessels 35
Fluorescent Lights 35
Endotoxins 35
Incubators 36
Biological Contamination 36
Varied Sources of Biological Contamination 37
Mycoplasmas 37
Airborne Particles and Aerosols 37
Cross Contamination by Other Cell Cultures 38
Consequences/Problems of Contamination 38
Controlling Cell Culture Contamination 38
Measures Aimed at Reducing Contamination Problems 39
6. REGULATORY ENVIRONMENT 40
7. PRODUCT INNOVATIONS/INTRODUCTIONS 41
StemCells Introduces GS1-R(TM) 41
Kollodis BioSciences Introduces Cell-Culture Reagents 41
The Automation Partnership Launches Automated Cell-Culture 41
Novartis Receives Approval to Release its New Vaccine 42
Invitrogen Introduces GIBCO® OpTmizer TM T-cell Expansion SFM 42
Novozymes Biopharma Rolls Out CellPrime in Partner ship with
Millipore 42
Invitrogen Launches Dynabeads® SSEA-4 43
Invitrogen Rolls Out KNOCKOUTTM SR XenoFree Media 43
Lonza Develops One-Step Program 43
Millipore Unveils ESGRO CompleteTM PLUS Medium 43
Millipore Introduces Hanging Millicell® Cell Culture Inserts 43
SAFC Biosciences® Launches EX-CELLTM EBx® 44
SAFC Biosciences® Rolls Out EX-Fusion and CHO Library 44
Millipore Launches Epidermal Keratinocyte 3D Medium 44
Invitrogen Rolls Out PD-Direct® Bioprocess Services 45
Millipore Unveils a New Variety of Primary Human Epithelial Cells 45
BD Biosciences Introduces BD Analysis Kit 46
Thermo Fisher Scientific Rolls Out Thermo Clone 46
Lonza Introduces Poietics® Human Natural Killer (NK) Cells 46
Millipore Launches New MillicoatTM Cultureware 47
Millipore Unveils High Content Analysis Kits 47
Millipore Rolls Out FlowCellect(TM) 47
Invitrogen Introduces GIBCO® Bottles 47
Invitrogen Unveils ST SFM, STEO and STEA Differentiation Kits 48
Thermo Fisher Scientific Launches NuncTM UpCellTM Surface 48
Millipore Releases New Primary Human Epithelial Cell Cultures 48
Millipore Expands Stem Cell Tested Initiative 49
BD Biosciences Debuts BD FACSAria(TM) II System to Sort Cells 49
Invitrogen Introduces Specific SFM for the Mesenchymal Stem Cells 49
StemCell Launches Cryopreservation Medium Free from Serum 50
Invitrogen Unveils SequalPrep(TM) System 50
Invitrogen Introduces Animal Source-Free Substrate 50
Invitrogen Introduces GIBCO® FoamAway(TM) Reagent 50
Genetix Develops New CytoGenetix Reagents and Kits 51
8. PRODUCT INTRODUCTIONS/INNOVATIONS IN THE RECENT PAST -
A PERSPECTIVE BUILDER 52
Thermo Fisher Launches NUNC In Vitro PDL Coated PETG Roller
Bottles 52
Thermo Fisher Scientific Introduces HyClone AdvanceSTEM(TM) Cell
Culture Product Line 52
Thermo Fisher Scientific Introduces New Medium to Culture PER
.C6 Cell Line 52
Genetix Expands CloneMedia Semi-Solid Media Products 52
Invitrogen Launches STEMPRO® EZPassage(TM) Tool 53
Sigma-Aldrich Introduces GenomePlex Tissue WGA Kit 53
Thermo Fisher Scientific Introduces Two New Versatile Media
for HEK 293 Cell Line 53
SAFC Biosciences Launches LONG®R3IGF-I in Liquid Form 53
Invitrogen and Novocell Introduce Media for hESC Growth 54
Invitrogen Releases New Culture System 54
Invitrogen Introduces New Line of Engineered Stem Cells 54
BD Biosciences Partners with StemCell Technologies 54
Millipore Launches MEL Cell Lines 55
Irvine Scientific Expands Industrial Cell Culture Product Line 55
Biovest International Introduces Automated Cell Culture Device 55
BD Biosciences Introduces BD FACSDiva(TM) 6.0 Software 56
Millipore Unveils Nylon Net Steriflip® Filter Unit 56
Lonza Expands Product-Portfolio with Serum Free Media 56
MediCult Unveils Flexible Culture Systems, BlastAssist® and
EmbryoAssist(TM) 56
Millipore Introduces New Medium for Human Embryonic Stem Cell
Research 57
Invitrogen Launches CytoGenie(TM) Cytometry Software Tool 57
Novozymes Releases New Cell Culture Components 57
The Automation Partnership Launches Advanced Plating Module 57
Nikon Unveils BioStation CT 58
Corning Launches Innovative Cell Culture Solutions 58
GroPep Introduces New Assay Kit for Cell Culture Business 58
HyClone Introduces HyQ®CDM4MAb(TM) for Hybridoma Cell Lines 58
INTEGRA Biosciences Adds Alarm Interface to CELLROLL and
CELLSPIN Systems 59
Nikon Launches New Imaging and Tracking Systems for Cell Culture 59
Genetix Develops Cell Dispenser 59
SAFC Biosciences Introduces LONGTMR3IGF-I for Industrial Cell
Culture 59
Biocrystal Presents Opticell 59
TAP Unveils CompacT SelecT(TM) 60
New Brunswick Scientific Augments New Products to Cell Culture
Systems 60
Cell Culture Technologies Develops Fortified Production Media 60
9. RECENT INDUSTRY ACTIVITY 61
Akron Biotechnology Merges with AppliChem 61
ChanTest Takes Over Applied Cell Sciences 61
Millipore to Takeover Guava Technologies 61
Millipore Acquires EpiTagTM Technology from Epitome Biosystems 62
MediCult's BlastAssist® Culture Media Obtains FDA Approval 62
Capsant Signs Commercialization Agreement with VistaGen 62
Millipore Inks Distribution Agreement with Solabia 63
Helix BioMedix Signs Production and Supply Agreement with
Peptisyntha 63
BD Biosciences to Establish New Production Facility 63
Lonza Group Takes Over amaxa 64
Millipore and Bayer Healthcare Sign Agreement 64
Applied Biosystems and Invitrogen Merge 64
SAFC BiosciencesTM and Celltrion Enter into Agreement 64
Tata Chemicals to Acquire Stake in Joil 65
Sartorius Stedim Biotech Acquires Wave Biotech 65
Sigma-Aldrich and AlphaGenix Sign Distribution Agreement 65
Induce Biologics and Therapure Biopharma Enter into Collaboration 65
International Stem Cell and Millipore Sign Distribution Agreement 65
Lonza Signs Agreement with Crucell 66
Eden Biodesign and Human Genome Sciences Sign Agreement 66
Becton, Dickinson to Establish New Production Facility 66
MedCell Bioscience Merges with NovaThera 66
Covidien UK Holding Takes Over Tissue Science Laboratories 67
Invitrogen Establishes Dedicated Business Unit for Cell Therapy 67
Invitrogen Signs Deal to Acquire CellzDirect 67
Invitrogen Renews Agreement with Luminex Corporation 67
BioTime Establishes Tissue Culture Facility 68
International Stem Cell Signs Agreement with ATCC 68
Millipore Signs Agreement with Solabia to Distribute Animal-
Free Hydrolysates 68
Affymetrix Acquires USB Corporation 69
SAFC to Expand Production Capacity of Viral Product 69
Lonza Signs Partnership Agreement with Sanofi to Produce Cell
Culture Vaccine 69
10. STRATEGIC CORPORATE ACTIVITY IN THE RECENT PAST -
A PERSPECTIVE BUILDER 70
SAFC to Increase Fermentation Capabilities of High-Potency API 70
Biogen Offers Contract to Jacobs Engineering Group 70
New Brunswick Scientific Merges with Eppendorf Group 70
Vitrolife Extends Agreement with Cellartis 70
Sigma-Aldrich Inks Distribution Agreement with CellPath 70
Lonza Acquires two Subsidiaries of Cambrex Bio-Businesses 71
Vikdas to Build Biotechnological Laboratory 71
Novartis to Invest in a New Cell Culture Plant in Singapore 71
Invitrogen Signs Agreement with Biocon 71
Lonza and Bio*One form Joint Venture for Mammalian Cell
Culture Plant 71
Thermo Fisher to Extend Manufacturing Operations 72
BD Biosciences Announces Treyburn Expansion Plans 72
BD Biosciences Collaborates with Roche to Advance Cell Signal
Transduction Study 72
Invitrogen and RXi Pharmaceuticals Enter into Collaboration 73
Millipore Forms a Strategic Alliance with Novozymes 73
Thermo Fisher Takes Over OptiCell Product Line 73
Invitrogen Collaborates with Cytori for Research on Adipose
Stem Cell 73
Thermo Fisher Partners with Cellular Engineering for Stem Cell
Research 74
VWR Signs Agreement to Distribute Biovest's Cell Culture Device 74
Genentech Constructs New Cell Culture Plant 74
Invitrogen Signs Deal with Wave Biotech to Offer Media-Filled
Disposable Bioreactors 74
MediCult Purchases Humagen Fertility 74
Millipore Acquires Serologicals 75
ReNeuron Inks Collaboration Agreement with CellSeed 75
Trans Valley Launches Tissue Cultured Variety of Mushrooms 75
HiMedia Laboratories Forges Distribution Deal with VWR
International 75
Teva Signs Collaboration Agreement with Protalix Biotherapeutics 75
SAFC-Biosciences Forms to Support Sigma-Aldrich 76
Invitrogen and Cellartis to Co-develop hESC Reporter Lines 76
CELLCA and Rentschler Join Forces for Unique High-Level
Expression System 76
ArcDia Partners with Chip-Man Technologies 76
Chugai Pharmaceutical Receives License for Cell Line from
Cambrex Bio Science Walkersville, Inc. 76
Chemicon Inks Distribution Agreement with CELLnTEC 77
Chemicon Signs an Agreement with ReNeuron 77
Chemicon to Market Stem Cell Products of ASCC 77
SCS and Chemicon Introduce ESGRO Complete(TM) Product Range 77
Serologicals Acquires Cytomyx Ltd 78
Millipore to Take Over Serologicals 78
CAT Opts SelectT(TM) for Higher Cell Culture Yields 78
11. FOCUS ON SELECT MAJOR PLAYERS 79
Affymetrix, Inc. (USA) 79
AMRESCO, Inc. (USA) 79
BD Biosciences (USA) 79
Cell Culture Technologies, LLC (Switzerland) 80
Cell Essentials, Inc. (USA) 80
Irvine Scientific (USA) 80
Life Technologies Corporation (USA) 80
Lonza Biologics Plc (UK) 81
Mediatech, Inc. (USA) 81
Millipore Corporation (USA) 81
Medi-Cult A/S (Denmark) 81
MP Biomedicals (USA) 82
PerBio Science AB (Sweden) 82
PromoCell GmbH (Germany) 82
Sera Laboratories International (UK) 82
Sigma-Aldrich Corporation (USA) 83
SAFC Biosciences (USA) 83
Vitrolife AB (Sweden) 83
12. GLOBAL MARKET PERSPECTIVE 84
Table 1: World Recent Past, Current & Future Analysis for
Cell/Tissue Culture Supplies by Geographic Region - USA,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 84
Table 2: World Historic Review for Cell/Tissue Culture
Supplies by Geographic Region - USA, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 85
Table 3: World 11-Year Perspective for Cell/Tissue Culture
Supplies by Geographic Region - Percentage Breakdown of Dollar
Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) & Latin America Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 86
Cell/Tissue Culture Supplies Market by Product Segment 87
Table 4: World Recent Past, Current & Future Analysis for
Media Cell/Tissue Culture Supplies by Geographic Region - USA,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 87
Table 5: World Historic Review for Media Cell/Tissue Culture
Supplies by Geographic Region - USA, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 88
Table 6: World 11-Year Perspective for Media Cell/Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) & Latin America Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 89
Table 7: World Recent Past, Current & Future Analysis for Sera
Cell/Tissue Culture Supplies by Geographic Region - USA,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 90
Table 8: World Historic Review for Sera Cell/Tissue Culture
Supplies by Geographic Region - USA, Canada, Japan, Europe,
Asia-Pacific (excluding Japan) and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 91
Table 9: World 11-Year Perspective for Sera Cell/Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) & Latin America Markets for Years2005, 2010 &
2015 (includes corresponding Graph/Chart) 92
Table 10: World Recent Past, Current & Future Analysis for
Reagent Cell/Tissue Culture Supplies by Geographic Region -
USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 93
Table 11: World Historic Review for Reagent Cell/Tissue
Culture Supplies by Geographic Region - USA, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 94
Table 12: World 11-Year Perspective for Reagent Cell/ Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) & Latin America Markets for Years2005, 2010 &
2015 (includes corresponding Graph/Chart) 95
13. THE UNITED STATES 96
A.Market Analysis 96
Current & Future Analysis 96
Cell & Tissue Culture Market 96
A Brief Insight 96
Market Trends 97
Trend Towards Serum-Free Media 97
Liquid and Powdered Media Account for Major Share 97
Table 13: Leading Players in the US Cell Culture Media
Market (2008): Percentage Breakdown of Sales for -
Sigma-Aldrich, Hyclone, Lonza Biologics, and Others
(includes corresponding Graph/Chart) 97
Fetal Bovine Serum - On A Decline 98
Rise in Cell Culture Equipment Demand Leads to Innovation 98
Market for Stem Cell Research 98
End-Use Analysis 99
Table 14: US Market for Cell Culture Reagents by End Use -
Academic, Industrial, and Non-Academic (2008) (includes
corresponding Graph/Chart) 99
Factors Influencing the Market for Tissue and Cell Culture
Media 99
Regulatory Controls 99
Guidelines Governing Use of Cell/Tissue Culture Reagents 100
MSDS and Hazardous Information 100
Toxic Substances Control Act 100
B.Market Analytics 101
Table 15: US Recent Past, Current & Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 101
Table 16: US Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 102
Table 17: US 11-Year Perspective for Cell/Tissue Culture
Supplies by Product Segment - Percentage Breakdown of Dollar
Sales for Media, Sera, and Reagents Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 103
14. CANADA 104
A.Market Analysis 104
Current & Future Analysis 104
Biotechnology Industry 104
B.Market Analytics 105
Table 18: Canadian Recent Past, Current & Future Analysis
for Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 105
Table 19: Canadian Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 106
Table 20: Canadian 11-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 106
15. JAPAN 107
A.Market Analysis 107
Current & Future Analysis 107
B.Market Analytics 107
Table 21: Japanese Recent Past, Current & Future Analysis
for Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 107
Table 22: Japanese Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 108
Table 23: Japanese 11-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 108
16. EUROPE 109
A.Market Analysis 109
Current & Future Analysis 109
Market Overview 109
B.Market Analytics 110
Table 24: European Recent Past, Current & Future Analysis
for Cell/Tissue Culture Supplies by Geographic Region -
France, Germany, UK, Italy & Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 110
Table 25: European Historic Review for Cell/Tissue Culture
Supplies by Geographic Region - France, Germany, UK, Italy
and Rest of Europe Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2006 (includes corresponding Graph/Chart) 111
Table 26: European Recent Past, Current & Future Analysis
for Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 112
Table 27: European Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 113
Table 28: European 11-Year Perspective for Cell/Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for France, Germany, UK, Italy & Rest of
Europe Markets for Years2005, 2010 & 2015 (includes
corresponding Graph/Chart) 114
Table 29: European 11-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 115
16a. FRANCE 116
Market Analysis 116
Current & Future Analysis 116
Table 30: French Recent Past, Current & Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 116
Table 31: French Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 117
Table 32: French 11-Year Perspective for Cell/Tissue Culture
Supplies by Product Segment - Percentage Breakdown of Dollar
Sales for Media, Sera, and Reagents Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 117
16b. GERMANY 118
A.Market Analysis 118
Current & Future Analysis 118
Biotech Research Scenario 118
Table 33: German Biotech Market (2009): Percentage
Breakdown by Application Area - Environment, Human Health
Care, Chemical industry, Food, Agriculture, Energy, and
Others (includes corresponding Graph/Chart) 119
B.Market Analytics 119
Table 34: German Recent Past, Current & Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 119
Table 35: German Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 120
Table 36: German 11-Year Perspective for Cell/Tissue Culture
Supplies by Product Segment - Percentage Breakdown of Dollar
Sales for Media, Sera, and Reagents Markets for Years2005,
2010 & 2015 (includes corresponding Graph/Chart) 120
16c. ITALY 121
Market Analysis 121
Current & Future Analysis 121
Table 37: Italian Recent Past, Current & Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 121
Table 38: Italian Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 122
Table 39: Italian 11-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 122
16d. THE UNITED KINGDOM 123
A.Market Analysis 123
Current & Future Analysis 123
Biotechnology Industry - A Brief Insight 123
Regulatory Issues 124
HFE Act Guidelines 124
The Ethical Issues 124
B.Market Analytics 125
Table 40: UK Recent Past, Current & Future Analysis for
Cell/Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 125
Table 41: UK Historic Review for Cell/Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) (includes corresponding
Graph/Chart) 126
Table 42: UK 11-Year Perspective for Cell/Tissue Culture
Supplies by Product Segment - Percentage Breakdown of Dollar
Sales for Media, Sera, and Reagents Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 126
16e. REST OF EUROPE 127
A.Market Analysis 127
Current & Future Analysis 127
Scenario in other European Countries 127
B.Market Analytics 128
Table 43: Rest of Europe Recent Past, Current & Future
Analysis for Cell/Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 128
Table 44: Rest of Europe Historic Review for Cell/Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 129
Table 45: Rest of Europe 11-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera and Reagent Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 130
17. ASIA-PACIFIC 131
A.Market Analysis 131
Current & Future Analysis 131
Rise of Cell Culture in Asia 131
India 131
Cell Culture Market Constituents 131
China 132
Taiwan 132
Australia 132
B.Market Analytics 133
Table 46: Asia-Pacific Recent Past, Current & Future
Analysis for Cell/Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 133
Table 47: Asia-Pacific Historic Review for Cell/Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 134
Table 48: Asia-Pacific 11-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera and Reagent Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 135
18. LATIN AMERICA 136
A.Market Analysis 136
Current & Future Analysis 136
Brazilian Biotech Industry 136
B.Market Analytics 137
Table 49: Latin American Recent Past, Current & Future
Analysis for Cell/Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 137
Table 50: Latin American Historic Review for Cell/Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 138
Table 51: Latin American 11-Year Perspective for Cell/Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera and Reagent Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 139
COMPETITION
Total Companies Profiled: 131 (including Divisions/Subsidiaries - 151)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 89
Canada 4
Japan 2
Europe 45
France 2
Germany 10
The United Kingdom 19
Spain 1
Rest of Europe 13
Asia-Pacific (Excluding Japan) 7
Latin America 1
Middle East 3
------------------------------------------
To order this report:
Biotechnology Industry: Global Cell/Tissue Culture Supplies Industry
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT: Nicolas BombourgReportlinkerEmail: [email protected]: +1-805-652-2626Intl: +1-805-652-2626
SOURCE Reportlinker
